S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

LGND Ligand Pharmaceuticals Incorporated

80.83

-7.08 (-8.05%)

05 Jun 2024 - Closed

Delayed by 15 minutes

Form 144/A - Report of proposed sale of securities: [Amend]

Ligand Pharmaceuticals (NASDAQ:LGND)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Ligand Pharmaceuticals Charts.

Ligand Pharmaceuticals (NASDAQ:LGND)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Ligand Pharmaceuticals Charts.

Ligand Pharmaceuticals Incorporated News

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 4 June 2024 (1 day ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 31 May 2024 (5 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 18 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 18 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 18 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 17 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 16 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 16 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144/A - Report of proposed sale of securities: [Amend]
Thursday 16 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 15 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Friday 10 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (3 months ago) • Edgar (US Regulatory)

More Ligand Pharmaceuticals Incorporated News Articles

NLBNPIT1YEC9 20240920 220

NLBNPIT1YWT5 20991231 33...

Societe Generale Effekten

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions